Intermittent Fasting & Heart Disease: Risks, Benefits, and What the Research Shows

Current research offers mixed signals about intermittent fasting (IF) and cardiovascular health. Some preliminary studies hint at a higher risk of cardiovascular mortality, while other evidence points to potential heart‑protective effects.

Intermittent fasting typically involves restricting food intake to a set daily window and abstaining from calories for the remaining hours. A common pattern is the 16:8 schedule—eating for eight hours (e.g., 10 a.m. to 6 p.m.) and fasting for the other sixteen.

This article reviews the existing data on IF and heart disease, and outlines who should approach fasting with caution.

Is IF Linked to Higher Cardiovascular Mortality?

A recent observational study of 20,078 U.S. adults recorded 840 cardiovascular deaths. The analysis found that participants who limited their eating window to **less than 8 hours per day** faced a statistically significant increase in cardiovascular‑related mortality compared with those who ate over a **12‑ to 16‑hour** window. No elevated risk was observed for windows between 8 and 10 hours, except among individuals already diagnosed with cardiovascular disease. Because the study relied on self‑reported eating patterns and short‑term follow‑up, causality cannot be confirmed, and further randomized trials are needed.

Potential Heart‑Health Benefits of IF

Conversely, a 2024 systematic review and meta‑analysis of randomized controlled trials highlighted several favorable outcomes associated with intermittent fasting:

• Reduced LDL‑cholesterol and triglyceride levels, which are key risk factors for heart attack and stroke.
• Increased HDL‑cholesterol (the “good” cholesterol) in overweight or obese participants.
• Greater preservation of fat‑free (lean) mass, which may help mitigate the risk of heart‑failure progression.
• Modest reductions in waist circumference, another marker linked to cardiovascular risk.

Some protocols, such as modified alternate‑day fasting, appeared especially effective for lowering fat mass.

Who Should Avoid or Modify IF?

Because IF can affect metabolism, hormone balance, and medication timing, it may be unsuitable for certain groups:

• Individuals under 18 years of age
• People over 75 years old
• Those with diabetes or on glucose‑affecting medications
• Pregnant or nursing individuals
• Persons who are underweight or have a history of eating disorders
• Anyone taking medications that require food intake for proper absorption

Patients with established cardiovascular disease should discuss fasting plans with their cardiologist or primary‑care physician, as time‑restricted eating could theoretically increase risk in this population.

Bottom Line

Evidence to date does not provide a definitive answer on whether intermittent fasting is overall safe or harmful for heart health. Short‑term data suggest that very narrow eating windows (<8 hours) might raise cardiovascular mortality risk, whereas broader windows and certain fasting regimens may improve lipid profiles and body composition.

Before starting any fasting protocol, especially if you have heart disease, diabetes, or are taking prescription drugs, consult a qualified healthcare professional. Personalized guidance will weigh potential benefits against individual risks.